Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Body mass index and survival in people with heart failure

JONES N. et al, (2023), Heart

Informed consent in randomised controlled trials: further development and evaluation of the participatory and informed consent (PIC) measure

Wade J. et al, (2023), Trials, 24

The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study

Sheppard JP. et al, (2023), PLOS Medicine, 20, e1004223 - e1004223

Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis.

Hartmann-Boyce J. et al, (2023), Circ Cardiovasc Qual Outcomes

Development of a modified Cambridge Multimorbidity Score for use with SNOMED CT: an observational English primary care sentinel network study.

Tsang RS. et al, (2023), Br J Gen Pract

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Butler CC. et al, (2023), The Lancet, 401, 281 - 293

COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study.

Bedston S. et al, (2023), Vaccine

BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record data.

Virdee PS. et al, (2023), Diagn Progn Res, 7

Face masks while exercising trial (MERIT): a cross-over randomised controlled study

Jones N. et al, (2023), BMJ open, 13

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study

Tsang RS. et al, (2023), Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 28

Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European arm of the World Organization of Family Doctors (WONCA Europe)

Herrera D. et al, (2023), Journal of Clinical Periodontology

Diagnostic accuracy of natriuretic peptide screening for left ventricular systolic dysfunction in the community: systematic review and meta-analysis

Goyder CR. et al, (2023), ESC Heart Failure

Natriuretic peptide testing and heart failure diagnosis in primary care: diagnostic accuracy study

Taylor CJ. et al, (2023), The British journal of general practice : the journal of the Royal College of General Practitioners, 73

Representativeness, Vaccination Uptake, and COVID-19 Clinical Outcomes 2020-2021 in the UK Oxford-Royal College of General Practitioners Research and Surveillance Network: Cohort Profile Summary

Leston M. et al, (2022), JMIR public health and surveillance, 8

Correction: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial (Trials, (2014), 15, 1, (160), 10.1186/1745-6215-15-160)

Hill NR. et al, (2022), Trials, 23

Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments

Cake C. et al, (2022), Trials, 23

Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales

Torabi F. et al, (2022), Scientific Reports, 12

Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

Simpson CR. et al, (2022), Nature Communications, 13

Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study

Archer L. et al, (2022), BMJ (Clinical research ed.), 379

Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial

Hawkey C. et al, (2022), The Lancet, 400, 1597 - 1606

Load More

1
2
3
4
5
6
7
...
»